Patent: 5,599,792
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 5,599,792
Title: | Bone-stimulating, non-vasoactive parathyroid hormone variants |
Abstract: | Described herein are Met.sup.8 -substituted variants of parathyroid hormone that retain bone stimulating activity yet, unlike their native counterparts, have substantially no vasoactivity. Their production using recombinant DNA-based techniques is also described, as is their therapeutic use, e.g. in the treatment of osteoporosis. |
Inventor(s): | Kronis; K. Anne (Toronto, CA), Bozzato; Richard P. (Etobicoke, CA) |
Assignee: | Allelix Biopharmaceuticals Inc. (Mississauga, CA) |
Application Number: | 08/332,453 |
Patent Claims: | see list of patent claims |
Details for Patent 5,599,792
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Sign Up | 2014-02-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |